(19)
(11) EP 4 543 461 A1

(12)

(43) Date of publication:
30.04.2025 Bulletin 2025/18

(21) Application number: 23830222.8

(22) Date of filing: 27.06.2023
(51) International Patent Classification (IPC): 
A61K 31/712(2006.01)
C12N 15/113(2010.01)
C07H 19/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/113; C12N 2310/11; C12N 2310/315; C12N 2310/341; C12N 2310/3515; C12N 2320/32; C12N 2310/3231; C12N 2310/3341; C12N 2320/11; C12N 2320/33; C07H 21/00; A61K 47/54; A61K 47/545; A61K 47/542
 
C-Sets:
C12N 2310/321, C12N 2310/3525;
(86) International application number:
PCT/CN2023/102618
(87) International publication number:
WO 2024/002045 (04.01.2024 Gazette 2024/01)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 27.06.2022 WO PCT/CN2022/101636
11.08.2022 WO PCT/CN2022/111702
07.12.2022 WO PCT/CN2022/137154

(71) Applicant: Aoan Biosciences
Suzhou, Jiangsu 215000 (CN)

(72) Inventors:
  • GAN, Zubao
    Nantong, Jiangsu 226400 (CN)
  • LI, Longcheng
    Nantong, Jiangsu 226400 (CN)
  • KANG, Moorim
    Nantong, Jiangsu 226400 (CN)

(74) Representative: Høiberg P/S 
Adelgade 12
1304 Copenhagen K
1304 Copenhagen K (DK)

   


(54) OLIGONUCLEOTIDE DELIVERY AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS USING THE SAME